No vaginal estrogen therapy arm in an RCT trial on genitourinary syndrome of menopause is a concern
- PMID: 31017495
- DOI: 10.1080/13697137.2019.1597842
No vaginal estrogen therapy arm in an RCT trial on genitourinary syndrome of menopause is a concern
Comment on
-
Rationale and design for fractional microablative CO2 laser versus photothermal non-ablative erbium:YAG laser for the management of genitourinary syndrome of menopause: a non-inferiority, single-blind randomized controlled trial.Climacteric. 2019 Jun;22(3):307-311. doi: 10.1080/13697137.2018.1559806. Epub 2019 Jan 24. Climacteric. 2019. PMID: 30676818
Similar articles
-
Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.Climacteric. 2018 Apr;21(2):148-152. doi: 10.1080/13697137.2018.1436538. Epub 2018 Feb 13. Climacteric. 2018. PMID: 29436235
-
'Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause': pelvic organ prolapse classification issues.Climacteric. 2018 Oct;21(5):515. doi: 10.1080/13697137.2018.1480601. Epub 2018 Aug 20. Climacteric. 2018. PMID: 30124335 No abstract available.
-
Laser Therapy for Genitourinary Syndrome of Menopause.Curr Urol Rep. 2018 Aug 17;19(10):83. doi: 10.1007/s11934-018-0831-y. Curr Urol Rep. 2018. PMID: 30117032 Review.
-
Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors.Menopause. 2017 Mar;24(3):316-319. doi: 10.1097/GME.0000000000000761. Menopause. 2017. PMID: 28231079
-
IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity.Int Urogynecol J. 2019 Mar;30(3):371-376. doi: 10.1007/s00192-018-3830-0. Epub 2018 Dec 6. Int Urogynecol J. 2019. PMID: 30523374 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources